Guidelines for the diagnosis and treatment of pulmonary hypertension: the Task Force for the Diagnosis and Treatment of Pulmonary Hypertension of the European …

N Galie, MM Hoeper, M Humbert, A Torbicki… - European heart …, 2009 - academic.oup.com
Thus, the task of writing Guidelines or Expert Consensus documents covers not only the
integration of the most recent research, but also the creation of educational tools and …

[HTML][HTML] Riociguat for the treatment of chronic thromboembolic pulmonary hypertension

…, AM D'Armini, F Grimminger, MM Hoeper… - … England Journal of …, 2013 - Mass Medical Soc
Background Riociguat, a member of a new class of compounds (soluble guanylate cyclase
stimulators), has been shown in previous clinical studies to be beneficial in the treatment of …

[HTML][HTML] Inhaled iloprost for severe pulmonary hypertension

…, S Nikkho, R Speich, MM Hoeper… - … England Journal of …, 2002 - Mass Medical Soc
Background Uncontrolled studies suggested that aerosolized iloprost, a stable analogue of
prostacyclin, causes selective pulmonary vasodilatation and improves hemodynamics and …

Definitions and diagnosis of pulmonary hypertension

MM Hoeper, HJ Bogaard, R Condliffe, R Frantz… - Journal of the American …, 2013 - jacc.org
Pulmonary hypertension (PH) is defined by a mean pulmonary artery pressure ≥25 mm Hg
at rest, measured during right heart catheterization. There is still insufficient evidence to add …

Diagnosis and assessment of pulmonary arterial hypertension

…, MM Hoeper, JE Loyd, A Manes, M McGoon… - Journal of the American …, 2009 - jacc.org
… In an example described by Hoeper (144), patients were assessed by 6MWD or CPET; goals
were 6MWD >380 m, peak oxygen consumption >10.4 ml/min/kg, and peak systolic blood …

2022 ESC/ERS Guidelines for the diagnosis and treatment of pulmonary hypertension: Developed by the task force for the diagnosis and treatment of pulmonary …

M Humbert, G Kovacs, MM Hoeper… - European heart …, 2022 - academic.oup.com
Pulmonary hypertension (PH) is a pathophysiological disorder that may involve multiple
clinical conditions and may be associated with a variety of cardiovascular and respiratory …

Chronic thromboembolic pulmonary hypertension (CTEPH) results from an international prospective registry

…, I Simkova, JA Barberą, M De Perrot, MM Hoeper… - Circulation, 2011 - Am Heart Assoc
Background— Chronic thromboembolic pulmonary hypertension (CTEPH) is often a sequel
of venous thromboembolism with fatal natural history; however, many cases can be cured by …

[HTML][HTML] Initial use of ambrisentan plus tadalafil in pulmonary arterial hypertension

…, AE Frost, HA Ghofrani, MM Hoeper… - … England Journal of …, 2015 - Mass Medical Soc
Background Data on the effect of initial combination therapy with ambrisentan and tadalafil
on long-term outcomes in patients with pulmonary arterial hypertension are scarce. Methods …

[HTML][HTML] Selexipag for the treatment of pulmonary arterial hypertension

…, N Galič, HA Ghofrani, MM Hoeper… - … England Journal of …, 2015 - Mass Medical Soc
Background In a phase 2 trial, selexipag, an oral selective IP prostacyclin-receptor agonist,
was shown to be beneficial in the treatment of pulmonary arterial hypertension. Methods In …

Phase 3 trial of sotatercept for treatment of pulmonary arterial hypertension

MM Hoeper, DB Badesch, HA Ghofrani… - … England Journal of …, 2023 - Mass Medical Soc
Hoeper can be contacted at hoeper . marius@ mh-hannover . de or at the Department of
Respiratory Medicine and Infectious Diseases, Hannover Medical School, Carl-Neuberg-…